Improvement of cardiometabolic markers after fish oil intervention in young Mexican adults and the role of PPARα L162V and PPARγ2 P12A.

[1]  E. Schaefer,et al.  Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial. , 2016, Metabolism: clinical and experimental.

[2]  A. Minihane,et al.  Interaction between BMI and APOE genotype is associated with changes in the plasma long-chain-PUFA response to a fish-oil supplement in healthy participants. , 2015, The American journal of clinical nutrition.

[3]  R. Villalobos-Molina,et al.  PREVALENCE OF METABOLIC SYNDROME IN YOUNG MEXICANS: A SENSITIVITY ANALYSIS ON ITS COMPONENTS. , 2015, Nutricion hospitalaria.

[4]  P. Ismail,et al.  Role of fish oil in human health and possible mechanism to reduce the inflammation , 2015, Inflammopharmacology.

[5]  P. Ivester,et al.  The impact of polyunsaturated fatty acid-based dietary supplements on disease biomarkers in a metabolic syndrome/diabetes population , 2014, Lipids in Health and Disease.

[6]  M. Vohl,et al.  Effects of FADS and ELOVL polymorphisms on indexes of desaturase and elongase activities: results from a pre-post fish oil supplementation , 2014, Genes & Nutrition.

[7]  S. Barquera,et al.  Classification of metabolic syndrome according to lipid alterations: analysis from the Mexican National Health and Nutrition Survey 2006 , 2014, BMC Public Health.

[8]  S. Ulven,et al.  Marine n-3 Fatty Acids and Gene Expression in Peripheral Blood Mononuclear Cells , 2014, Current Cardiovascular Risk Reports.

[9]  H. Roche,et al.  Nutritional aspects of metabolic inflammation in relation to health--insights from transcriptomic biomarkers in PBMC of fatty acids and polyphenols. , 2014, Molecular nutrition & food research.

[10]  P. Calder,et al.  Genome-wide association study of the plasma triglyceride response to an n-3 polyunsaturated fatty acid supplementation[S] , 2014, Journal of Lipid Research.

[11]  A. Scholey,et al.  Randomized Controlled Trial Examining the Effects of Fish Oil and Multivitamin Supplementation on the Incorporation of n-3 and n-6 Fatty Acids into Red Blood Cells , 2014, Nutrients.

[12]  C. Schacky.  Omega-3 index and cardiovascular health. , 2014 .

[13]  Trevor A. Mori,et al.  Dietary n-3 PUFA and CVD: a review of the evidence , 2013, Proceedings of the Nutrition Society.

[14]  O. Obeid,et al.  Combined Fish Oil and High Oleic Sunflower Oil Supplements Neutralize their Individual Effects on the Lipid Profile of Healthy Men , 2013, Lipids.

[15]  M. Moreno-Aliaga,et al.  Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence , 2013, Journal of Physiology and Biochemistry.

[16]  Neffati Fadoua,et al.  Interaction Effects of the Leu162Val PPARα and Pro12Ala PPARγ2 Gene Variants with Renal Function in Metabolic Syndrome Population , 2013, PPAR research.

[17]  M. Vohl,et al.  Effects of Age, Sex, Body Mass Index and APOE Genotype on Cardiovascular Biomarker Response to an n-3 Polyunsaturated Fatty Acid Supplementation , 2013, Lifestyle Genomics.

[18]  M. Garg,et al.  Eicosapentaenoic and docosahexaenoic acid supplementations reduce platelet aggregation and hemostatic markers differentially in men and women. , 2013, The Journal of nutrition.

[19]  M. Krebs,et al.  Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. , 2012, The American journal of clinical nutrition.

[20]  A. Lichtenstein,et al.  Regulation of the expression of key genes involved in HDL metabolism by unsaturated fatty acids. , 2012, The British journal of nutrition.

[21]  E. Ntzani,et al.  Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. , 2012, JAMA.

[22]  W. Harris,et al.  Fish oil -- how does it reduce plasma triglycerides? , 2012, Biochimica et biophysica acta.

[23]  J. Meigs,et al.  Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials. , 2011, Clinical nutrition.

[24]  T. Isbir,et al.  Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes , 2011, Molecular and Cellular Biochemistry.

[25]  H. Cordell,et al.  The impact of common gene variants on the response of biomarkers of cardiovascular disease (CVD) risk to increased fish oil fatty acids intakes. , 2011, Annual review of nutrition.

[26]  S. Villalpando,et al.  Fatty acids intake in the Mexican population. Results of the National Nutrition Survey 2006 , 2011, Nutrition & metabolism.

[27]  B. Meyer,et al.  Effects of Seal Oil and Tuna-Fish Oil on Platelet Parameters and Plasma Lipid Levels in Healthy Subjects , 2010, Lipids.

[28]  Y. Deshaies,et al.  PPARalpha L162V polymorphism alters the potential of n-3 fatty acids to increase lipoprotein lipase activity. , 2010, Molecular nutrition & food research.

[29]  J. Ordovás,et al.  Fatty acid interactions with genetic polymorphisms for cardiovascular disease , 2010, Current opinion in clinical nutrition and metabolic care.

[30]  G. Sagoo,et al.  The Association Between the Peroxisome Proliferator-Activated Receptor-γ2 (PPARG2) Pro12Ala Gene Variant and Type 2 Diabetes Mellitus: A HuGE Review and Meta-Analysis , 2010, American journal of epidemiology.

[31]  M. Hutz,et al.  The Influence of Nutrigenetics on the Lipid Profile: Interaction Between Genes and Dietary Habits , 2010, Biochemical Genetics.

[32]  M. Quon,et al.  Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. , 2009, Atherosclerosis.

[33]  A. Geelen,et al.  No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals , 2009, European Journal of Clinical Nutrition.

[34]  M. Vohl,et al.  Omega-3 fatty acids regulate gene expression levels differently in subjects carrying the PPARα L162V polymorphism , 2009, Genes & Nutrition.

[35]  M. Vohl,et al.  Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE ɛ4 but not by the common PPAR-α L162V polymorphism in men , 2009, British Journal of Nutrition.

[36]  P. Ivester,et al.  Effect of Dietary Fatty Acids on Inflammatory Gene Expression in Healthy Humans* , 2009, The Journal of Biological Chemistry.

[37]  Johan Trygg,et al.  CV‐ANOVA for significance testing of PLS and OPLS® models , 2008 .

[38]  R. Rabasa-Lhoret,et al.  Nutritional intervention to reduce the n−6/n−3 fatty acid ratio increases adiponectin concentration and fatty acid oxidation in healthy subjects , 2008, European Journal of Clinical Nutrition.

[39]  F. Schick,et al.  The L162V polymorphism of the peroxisome proliferator activated receptor alpha gene (PPARA) is not associated with type 2 diabetes, BMI or body fat composition. , 2008, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[40]  M. Vohl,et al.  Effect of the PPAR-Alpha L162V Polymorphism on the Cardiovascular Disease Risk Factor in Response to n–3 Polyunsaturated Fatty Acids , 2008, Lifestyle Genomics.

[41]  Eric Boerwinkle,et al.  Peroxisome proliferator–activated receptor α genetic variation interacts with n−6 and long-chain n−3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study , 2008 .

[42]  M. Kiely,et al.  Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults , 2008, Diabetologia.

[43]  M. Liu,et al.  Single gene contributions: genetic variants of peroxisome proliferator-activated receptor (isoforms α, β/δ and γ) and mechanisms of dyslipidemias , 2008, Current opinion in lipidology.

[44]  P. Calder,et al.  Influence of very long-chain n-3 fatty acids on plasma markers of inflammation in middle-aged men. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[45]  J. Bassaganya-Riera,et al.  Dietary Modulators of Peroxisome Proliferator-Activated Receptors: Implications for the Prevention and Treatment of Metabolic Syndrome , 2008, Lifestyle Genomics.

[46]  G. Pierce,et al.  A Comparison of Fish Oil, Flaxseed Oil and Hempseed Oil Supplementation on Selected Parameters of Cardiovascular Health in Healthy Volunteers , 2008, Journal of the American College of Nutrition.

[47]  A. Rodgers,et al.  International Physical Activity Questionnaire (IPAQ) and New Zealand Physical Activity Questionnaire (NZPAQ): A doubly labelled water validation , 2007, The international journal of behavioral nutrition and physical activity.

[48]  M. Uusitupa,et al.  Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids? , 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[49]  E. Hoffman,et al.  PPARα L162V underlies variation in serum triglycerides and subcutaneous fat volume in young males , 2007, BMC Medical Genetics.

[50]  P. Calder,et al.  Age- and dose-dependent effects of an eicosapentaenoic acid-rich oil on cardiovascular risk factors in healthy male subjects. , 2007, Atherosclerosis.

[51]  T. Hansen,et al.  Relationships between the functional PPARalpha Leu162Val polymorphism and obesity, type 2 diabetes, dyslipidaemia, and related quantitative traits in studies of 5799 middle-aged white people. , 2007, Molecular genetics and metabolism.

[52]  P. Calder.  n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. , 2006, The American journal of clinical nutrition.

[53]  T. Sanders,et al.  Influence of an algal triacylglycerol containing docosahexaenoic acid (22:6n-3) and docosapentaenoic acid (22:5n-6) on cardiovascular risk factors in healthy men and women , 2006, British Journal of Nutrition.

[54]  P. Calder,et al.  Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. , 2006, The American journal of clinical nutrition.

[55]  R. Bugarini,et al.  Blood profiles, body fat and mood state in healthy subjects on different diets supplemented with Omega‐3 polyunsaturated fatty acids , 2005, European journal of clinical investigation.

[56]  E. Tai,et al.  Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study. , 2005, The Journal of nutrition.

[57]  Y. Bossé,et al.  The peroxisome proliferator-activated receptor alpha Leu162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men. , 2005, The American journal of clinical nutrition.

[58]  W. Harris,et al.  The Omega-3 Index: a new risk factor for death from coronary heart disease? , 2004, Preventive medicine.

[59]  S. Clarke.  The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors , 2004, Current opinion in lipidology.

[60]  R. Vigneri,et al.  Evidence for genetic epistasis in human insulin resistance: the combined effect of PC-1 (K121Q) and PPARγ2 (P12A) polymorphisms , 2003, Journal of Molecular Medicine.

[61]  M. Laakso,et al.  Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation. , 2003, Molecular genetics and metabolism.

[62]  P. Wilson,et al.  Association Between the PPARA L162V Polymorphism and Plasma Lipid Levels: The Framingham Offspring Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[63]  S. Wold,et al.  PLS-regression: a basic tool of chemometrics , 2001 .

[64]  M. Stumvoll,et al.  Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity. , 2001, Diabetes.

[65]  M. Richard,et al.  Effects of fish oil fatty acids on plasma lipids and lipoproteins and oxidant-antioxidant imbalance in healthy subjects. , 1999, Scandinavian journal of clinical and laboratory investigation.

[66]  I. Romieu,et al.  Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. , 1998, Salud publica de Mexico.

[67]  O. Carvajal,et al.  Effect of n-3 polyunsaturated fatty acids on the lipidic profile of healthy Mexican volunteers. , 1997, Salud publica de Mexico.

[68]  Christine M. Williams,et al.  Effects of n-3 fatty acids on postprandial triacylglycerol and hormone concentrations in normal subjects , 1992, British Journal of Nutrition.

[69]  B. G. Hughes,et al.  Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal. , 1988, Biochemical and biophysical research communications.

[70]  M. Arita,et al.  Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. , 2016, Journal of cardiology.

[71]  Manabu T. Nakamura,et al.  Regulation of energy metabolism by long-chain fatty acids. , 2014, Progress in lipid research.

[72]  P. Flachs,et al.  The effect of n-3 fatty acids on glucose homeostasis and insulin sensitivity. , 2014, Physiological research.

[73]  M. Vohl,et al.  Transcriptomic and metabolomic signatures of an n-3 polyunsaturated fatty acids supplementation in a normolipidemic/normocholesterolemic Caucasian population. , 2013, The Journal of nutritional biochemistry.

[74]  M. Kunesova,et al.  Role of the PPARalpha Leu162Val and PPARgamma2 Pro12Ala gene polymorphisms in weight change after 2.5-year follow-up in Czech obese women. , 2010, Folia biologica.

[75]  P. Flachs,et al.  Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. , 2009, Clinical science.

[76]  B. Gower,et al.  Increased n-6 polyunsaturated fatty acids do not attenuate the effects of long-chain n-3 polyunsaturated fatty acids on insulin sensitivity or triacylglycerol reduction in Indian Asians. , 2004, American Journal of Clinical Nutrition.

[77]  J. C. Díaz-Zagoya,et al.  Comparative analysis of erythrocyte fatty acid composition in a sample of Mexico City children and young adults on a free diet. , 1993, Archives of medical research.